Page last updated: 2024-11-03

ono 1078 and Neuroblastoma

ono 1078 has been researched along with Neuroblastoma in 1 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peng, F1
Fang, SH1
Zheng, XL1
Zhang, WP1
Lu, YB1
Wei, EQ1

Other Studies

1 other study available for ono 1078 and Neuroblastoma

ArticleYear
[Cysteinyl leukotriene receptor 1 antagonist pranlukast modulates differentiation of SK-N-SH cells].
    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2007, Volume: 36, Issue:2

    Topics: Cell Differentiation; Cell Line, Tumor; Chromones; Humans; Immunoblotting; Immunohistochemistry; Leu

2007